Global Markets Direct’s pharmaceuticals report, “Kiadis Pharma B.V. - Product Pipeline Review - 2013” provides data on the Kiadis Pharma B.V.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Kiadis Pharma B.V.’s corporate website, SEC filings, investor presentations and featured press releases, both from Kiadis Pharma B.V. and industry-specific third party sources, put together by Global Markets Direct’s team.
- Kiadis Pharma B.V. - Brief Kiadis Pharma B.V. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Kiadis Pharma B.V. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Kiadis Pharma B.V. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Kiadis Pharma B.V.’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate Kiadis Pharma B.V.’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Kiadis Pharma B.V. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Kiadis Pharma B.V.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Kiadis Pharma B.V.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Kiadis Pharma B.V. and identify potential opportunities in those areas.
Table Of Contents
Kiadis Pharma B.V. - Product Pipeline Review - 2013 Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Kiadis Pharma B.V. Snapshot 4 Kiadis Pharma B.V. Overview 4 Key Information 4 Key Facts 4 Kiadis Pharma B.V. - Research and Development Overview 5 Key Therapeutic Areas 5 Kiadis Pharma B.V. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Kiadis Pharma B.V. - Pipeline Products Glance 9 Kiadis Pharma B.V. Clinical Stage Pipeline Products 9 Phase II Products/Combination Treatment Modalities 9 Phase I Products/Combination Treatment Modalities 10 Kiadis Pharma B.V. - Drug Profiles 11 ATIR 11 Product Description 11 Mechanism of Action 11 RandD Progress 11 Reviroc 12 Product Description 12 Mechanism of Action 12 RandD Progress 12 Rhitol 13 Product Description 13 Mechanism of Action 13 RandD Progress 13 Kiadis Pharma B.V. - Pipeline Analysis 14 Kiadis Pharma B.V. - Pipeline Products by Therapeutic Class 14 Kiadis Pharma B.V. - Pipeline Products by Route of Administration 15 Kiadis Pharma B.V. - Recent Pipeline Updates 16 Kiadis Pharma B.V. - Dormant Projects 17 Kiadis Pharma B.V. - Locations And Subsidiaries 18 Head Office 18 Appendix 19 Methodology 19 Coverage 19 Secondary Research 19 Primary Research 19 Expert Panel Validation 19 Contact Us 20 Disclaimer 20
List of Tables
Kiadis Pharma B.V., Key Information 4 Kiadis Pharma B.V., Key Facts 4 Kiadis Pharma B.V. - Pipeline by Indication, 2013 6 Kiadis Pharma B.V. - Pipeline by Stage of Development, 2013 7 Kiadis Pharma B.V. - Monotherapy Products in Pipeline, 2013 8 Kiadis Pharma B.V. - Phase II, 2013 9 Kiadis Pharma B.V. - Phase I, 2013 10 Kiadis Pharma B.V. - Pipeline By Therapeutic Class, 2013 14 Kiadis Pharma B.V. - Pipeline By Route of Administration, 2013 15 Kiadis Pharma B.V. - Recent Pipeline Updates, 2013 16 Kiadis Pharma B.V. - Dormant Developmental Projects,2013 17
List of Figures
Kiadis Pharma B.V. - Pipeline by Indication, 2013 6 Kiadis Pharma B.V. - Pipeline by Stage of Development, 2013 7 Kiadis Pharma B.V. - Monotherapy Products in Pipeline, 2013 8 Kiadis Pharma B.V. - Pipeline By Therapeutic Class, 2013 14 Kiadis Pharma B.V. - Pipeline By Route of Administration, 2013 15